New drug aims to free patients from frequent blood draws
NCT ID NCT05143957
Summary
This study is testing an investigational drug called sapablursen to see if it can reduce the need for frequent therapeutic blood draws (phlebotomy) in people with polycythemia vera. About 50 participants will receive injections under the skin for about 8 months to see if the treatment works and is safe. The main goal is to help patients manage their condition with fewer medical procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHLEBOTOMY DEPENDENT POLYCYTHEMIA VERA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Border Medical Oncology Research Unit
Albury, 2640, Australia
-
Calvary Mater Newcastle Hospital
Waratah, New South Wales, 2298, Australia
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
John Theurer Cancer Center
Hackensack, New Jersey, 07601, United States
-
MICS Centrum Medyczne Toruń
Torun, 87-100, Poland
-
Mayo Clinic Hospital
Phoenix, Arizona, 85054, United States
-
McGill University Health Centre
Montreal, Quebec, H4A 3J1, Canada
-
O'Neal Comprehensive Cancer Center University of Alabama at Birmingham
Birmingham, Alabama, 35249, United States
-
Oxford University Hospitals NHS Foundation Trust
Oxford, England, OX37LE, United Kingdom
-
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie, Klinika Hematoonkologii i Transplantacji Szpiku
Lublin, 20-081, Poland
-
University College London Hospitals NHS Foundation Trust
London, NW1 2PG, United Kingdom
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Wojewódzki Szpital Specjalistyczny Sp. z o.o.
Słupsk, 76-200, Poland
Conditions
Explore the condition pages connected to this study.